TFIIA-γ Antibodies

Santa Cruz Biotechnology delivers a wide array of TFIIA-γ monoclonal antibodies for research focused on understanding this essential transcription factor. TFIIA-γ monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFIIA-γ is a critical component of the transcription machinery, playing a vital role in the initiation of gene expression by stabilizing the binding of transcription factors to DNA. Its function is crucial in regulating various cellular processes, including cell growth, differentiation, and response to stress. Understanding the dynamics of TFIIA-γ is important for elucidating the mechanisms underlying gene regulation and its implications in diseases. TFIIA-γ monoclonal antibodies enable researchers to explore the complex interactions between transcription factors and DNA. Investigating TFIIA-γ activity provides valuable insights into fundamental cellular processes and potential therapeutic targets. Researchers can utilize TFIIA-γ monoclonal antibodies to examine protein expression patterns across different tissue types and experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of transcriptional regulation and its impact on human health.